Weekly fluorouracil at 425 mg/m(2) plus low-dose folinic acid for 24 weeks as adjuvant treatment for colorectal cancer: assessment of toxicity and delivery.

Ramani, V S; Gollins, S W; Wong, H

Ramani, V S; Gollins, S W; Wong, H.

Affiliation

Ramani VS; Clatterbridge Centre for Oncology, Bebington, Wirral, UK.

Clin Oncol (R Coll Radiol) ; 18(9): 649-57, 2006 Nov.

Article in En | MEDLINE | ID: mdl-17100149

Subject(s)

Colorectal Neoplasms/drug therapy; Fluorouracil/administration & dosage; Leucovorin/administration & dosage; Adult; Aged; Aged, 80 and over; Chemotherapy, Adjuvant/adverse effects; Colorectal Neoplasms/surgery; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Delivery Systems; Female; Fluorouracil/adverse effects; Humans; Leucovorin/adverse effects; Male; Middle Aged; Patient Compliance; Withholding Treatment/statistics & numerical data

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Colorectal Neoplasms / Leucovorin / Fluorouracil Type of study: Clinical_trials Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Clin Oncol (R Coll Radiol) Journal subject: NEOPLASIAS Year: 2006 Document type: Article Affiliation country: United kingdom Country of publication: United kingdom

Search on Google

Add to My VHL

XML

PubMed Links